EVMN
Evommune, Inc.
NYSE · Healthcare · Biotechnology · US
$9.65
+2.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 91.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.26x
- Price / sales
- 35.02x
- Price / cash flow
- -4.72x
Enterprise value
- Enterprise value
- $157.5M
- EV / sales
- 15.75x
- EV / EBITDA
- -1.64x
- EV / EBIT
- -1.55x
- Market cap
- $350.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026